全文获取类型
收费全文 | 3927篇 |
免费 | 274篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 76篇 |
妇产科学 | 52篇 |
基础医学 | 468篇 |
口腔科学 | 113篇 |
临床医学 | 366篇 |
内科学 | 948篇 |
皮肤病学 | 83篇 |
神经病学 | 126篇 |
特种医学 | 134篇 |
外科学 | 419篇 |
综合类 | 126篇 |
一般理论 | 2篇 |
预防医学 | 348篇 |
眼科学 | 78篇 |
药学 | 484篇 |
4篇 | |
中国医学 | 74篇 |
肿瘤学 | 256篇 |
出版年
2024年 | 21篇 |
2023年 | 74篇 |
2022年 | 237篇 |
2021年 | 336篇 |
2020年 | 178篇 |
2019年 | 170篇 |
2018年 | 216篇 |
2017年 | 140篇 |
2016年 | 161篇 |
2015年 | 155篇 |
2014年 | 202篇 |
2013年 | 208篇 |
2012年 | 346篇 |
2011年 | 344篇 |
2010年 | 186篇 |
2009年 | 146篇 |
2008年 | 169篇 |
2007年 | 144篇 |
2006年 | 160篇 |
2005年 | 130篇 |
2004年 | 123篇 |
2003年 | 91篇 |
2002年 | 68篇 |
2001年 | 20篇 |
2000年 | 26篇 |
1999年 | 23篇 |
1998年 | 11篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 10篇 |
1994年 | 10篇 |
1993年 | 8篇 |
1992年 | 11篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 4篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 2篇 |
1981年 | 4篇 |
1979年 | 6篇 |
1975年 | 2篇 |
1972年 | 2篇 |
1935年 | 1篇 |
1931年 | 1篇 |
1929年 | 1篇 |
1923年 | 2篇 |
排序方式: 共有4223条查询结果,搜索用时 15 毫秒
71.
Cho I Chang HJ Sung JM Pencina MJ Lin FY Dunning AM Achenbach S Al-Mallah M Berman DS Budoff MJ Callister TQ Chow BJ Delago A Hadamitzky M Hausleiter J Maffei E Cademartiri F Kaufmann P Shaw LJ Raff GL Chinnaiyan KM Villines TC Cheng V Nasir K Gomez M Min JK;CONFIRM Investigators 《Circulation》2012,126(3):304-313
72.
Ahmed HM Blaha MJ Nasir K Rivera JJ Blumenthal RS 《The American journal of cardiology》2012,109(2):288-295
Much attention has been directed toward lifestyle modifications as effective means of reducing cardiovascular disease risk. In particular, physical activity has been heavily studied because of its well-known effects on metabolic syndrome, insulin sensitivity, cardiovascular disease risk, and all-cause mortality. However, data regarding the effects of exercise on various stages of the atherosclerosis pathway remain conflicting. The investigators review previously published reports for recent observational and interventional trials investigating the effects of physical activity on markers of (or causal factors for) atherosclerotic burden and vascular disease, including serum lipoproteins, systemic inflammation, thrombosis, coronary artery calcium, and carotid intima-media thickness. In conclusion, the data show a correlation between physical activity and triglyceride reduction, apolipoprotein B reduction, high-density lipoprotein increase, change in low-density lipoprotein particle size, increase in tissue plasminogen activator activity, and decrease in coronary artery calcium. Further research is needed to elucidate the effect of physical activity on inflammatory markers and intima-media thickness. 相似文献
73.
We assessed the clinical echocardiograhic, hematological, and biochemical parameters in patients with dilated cardiomyopathy (DCMP) and control individuals mainly focusing on the mean platelet volume (MPV) in terms of DCMP and left ventricle (LV) thrombus formation. Consecutive patients (n = 251) with DCMP and 266 patients without DCMP were studied. Mean platelet volume was significantly greater in patients with DCMP than in control patients (P < .05 for all comparisons). Comparing DCMP patients with LV thrombus (19 patients, 8%) and without LV thrombus (232 patients, 92%) showed that the prevalence of smokers was significantly higher and ejection fraction was significantly lower in patients with LV thrombus. We have shown that patients with DCMP have significantly higher MPV suggesting more platelet activation and the MPV of patients with DCMP and LV thrombus is comparable to those of patients without LV thrombus. 相似文献
74.
Nafeeza Mohd Ismail Ibrahim Abdel Aziz Ibrahim Najihah Binti Mohd Hashim Kamsiah Jaarin 《Archives of Medical Science》2013,9(6):1132-1137
Introduction
Captopril is an angiotensin-converting enzyme inhibitor, which is used as an antihypertensive agent and has shown antioxidant properties. This study aims at determining the effects of captopril on factors affecting gastric mucosal integrity in aspirin-induced gastric lesions.Material and methods
Eighteen male Sprague-Dawley (200-250 g) rats that were given aspirin (40 mg/100 g body weight) were divided into three groups: the control, captopril (1 mg/100 g body weight daily) and ranitidine (2.5 mg/100 g body weight twice daily) groups. Ranitidine and captopril were given orally for 28 days. Rats in all groups were sacrificed and the parameters measured.Results
Captopril reduced gastric acidity, and increased gastric glutathione (GSH) and prostaglandin E2 (PGE2) significantly in comparison to the control group. Captopril also reduced malondialdehyde (MDA) and gastric lesions insignificantly compared to the control group. Ranitidine healed the lesions significantly compared to the control group. There was no difference between ranitidine and captopril on the severity of lesions, gastric acidity, MDA and GSH. Captopril increased PGE2 compared to ranitidine (p < 0.05).Conclusions
Captopril has desirable effects on the factors affecting gastric mucosal integrity (acidity, PGE2 and GSH) and is comparable to ranitidine in ulcer healing. 相似文献75.
Lima MA de Farias EH Gray A Sadeghi N Gesteira TF Cavalheiro RP Hoppensteadt D Fareed J Sassaki GL Nader HB 《Clinical and applied thrombosis/hemostasis》2012,18(4):379-386
Generic active pharmaceutical ingredients (APIs) have been commonly used in Brazil, since 1999, but most of them are synthetic and small molecules. Recently, a large number of generic enoxaparins were introduced into the market raising concerns related to product-to-product interchangeability, efficiency, and drug counterfeiting. These drugs are produced from biological sources and their production involves complex procedures and purification processes. The present article evaluates several generic enoxaparins, structurally and pharmacologically, and compares them with the branded products. Structural analysis showed that the generic products are, indeed, quite similar to the branded products, however, this similarity cannot be extended to their pharmacological activities. The results showed that generic products must go through extensive structural, pharmacological, and clinical evaluation in order to assess their quality, efficacy and, ultimately, avoid drug counterfeiting before clinical use. Variation was also observed between the branded products, showing that such drugs must be at constant surveillance. 相似文献
76.
M. H. M. Mubassir M. Abu Naser Mohd Firdaus Abdul-Wahab Tanvir Jawad Raghib Ishraq Alvy Salehhuddin Hamdan 《RSC advances》2020,10(27):15800
The first layer of defense that plants deploy to ward off a microbial invasion comes in the form of pattern-triggered immunity (PTI), which is initiated when the pattern-recognition receptors (PRRs) bind with the pathogen-associated molecular patterns (PAMPs) and co-receptor proteins, and transmit a defense signal. Although several plant PRRs have been discovered, very few of them have been fully characterized, and their functional parameters assessed. In this study, the 3D-model prediction of an entire plant PRR protein, Xa21, was done by implementing multiple in silico modeling techniques. Subsequently, the PAMP RaxX21-sY (sulphated RaxX21) and leucine-rich repeat (LRR) domain of the co-receptor OsSERK2 were docked with the LRR domain of Xa21. The docked complex of these three proteins formed a heterodimer that closely resembles the other crystallographic PTI complexes available. Molecular dynamics simulations and MM/PBSA calculations were applied for an in-depth analysis of the interactions between Xa21 LRR, RaxX21-sY, and OsSERK2 LRR. Arg230 and Arg185 from Xa21 LRR, Val2 and Lys15 from RaxX21-sY and Lys164 from OsSERK2 LRR were found to be the prominent residues which might contribute significantly in the formation of a heterodimer during the PTI process mediated by Xa21. Additionally, RaxX21-sY interacted much more favorably with Xa21 LRR in the presence of OsSERK2 LRR in the complex, which substantiates the necessity of the co-receptor in Xa21 mediated PTI to recognize the PAMP RaxX21-sY. However, the free energy binding calculation reveals the favorability of a heterodimer formation of PRR Xa21 and co-receptor OsSERK2 without the presence of PAMP RaxX21-sY, which validate the previous lab result.This study exhausts bioinformatics tools to acquire the entire multi-domain rice Xa21 protein structure and analyzes its interactions with its PAMP RaxX21-sY and co-receptor OsSERK2. 相似文献
77.
Nashrah Sharif Khan Parvez Khan Afreen Inam Kamal Ahmad Mohd. Yousuf Asimul Islam Sher Ali Amir Azam Mohammad Husain Md. Imtaiyaz Hassan 《RSC advances》2020,10(34):20129
Microtubule affinity regulating kinase 4 (MARK4) is a Ser/Thr kinase, considered as a potential drug target for cancer, diabetes and neurodegenerative diseases. Due to its significant role in the development and progression of cancer, different in-house libraries of synthesized small molecules were screened to identify potential MARK4 inhibitors. A small library of hydrazone compounds showed a considerable binding affinity to MARK4. The selected compounds were further scrutinized using an enzyme inhibition assay and finally two hydrazone derivatives (H4 and H19) were selected that show excellent inhibition (nM range). These compounds have a strong binding affinity for MARK4 and moderate binding with human serum albumin. Anticancer studies were performed on MCF-7 and A549 cells, suggesting H4 and H19 selectively inhibit the growth of cancer cells. The IC50 value of compound H4 and H19 was found to be 27.39 μM and 34.37 μM for MCF-7 cells, while for A549 cells it was 45.24 μM and 61.50 μM, respectively. These compounds inhibited the colonogenic potential of cancer cells and induced apoptosis. Overall findings reflect that hydrazones/hydrazone derivatives could be exploited as potential lead molecules for developing effective anticancer therapies via targeting MARK4.Inhibition studies of MARK4 with selected hydrazone derivatives. 相似文献
78.
Jamal Kazmi Poh Choon Ooi Boon Tong Goh Min Kai Lee M. F. Mohd. Razip Wee Siti Shafura A Karim Syed Raza Ali Raza Mohd Ambri Mohamed 《RSC advances》2020,10(39):23297
Room-temperature ferromagnetism in the large and direct bandgap diluted magnetic semiconductor zinc oxide (ZnO) is attributed to the intrinsic defects and p-orbital–p-orbital (p–p) coupling interaction. However, due to oxidation, the ferromagnetism induced by defects is unstable. In the present work, the solution process synthesis route was utilized to grow pristine and bismuth-doped, highly crystalline ZnO nanowire (ZnO NW)-based samples. The FE-SEM images showed that the grown ZnO NWs have a preferred orientation along the c-axis in the (001) direction due to the anisotropic crystal nature of ZnO. X-ray photoelectron spectroscopy (XPS) confirmed the presence of Bi, and at a higher doping content, the bismuth oxide phase appeared. The XRD patterns showed the wurtzite crystal structure, and the large intensity of the (002) peak suggests that most of the reflection was from the top hexagonal face of the NWs, and thus, the wires are predominantly aligned along the c-axis. The TEM analysis further confirmed the crystal growth direction along the (001) direction. The UV-Visible absorption and PL measurements also showed a decrease in the bandgap with an increase in doping concentration, which may be associated with the sp–d exchange interaction between the localized d-electrons and band electrons of the Bi ions. Bi-doping tended to increase the PL intensity in the visible region. The magnetic properties measured by SQUID at 4 and 300 K showed ferromagnetic behaviour for both the pristine and Bi-doped samples. However, the saturation magnetization for the Bi-doped samples was higher compared to that of the pristine ZnO samples until the threshold doping value. The obtained results demonstrated that Bi-doping can be used to tune both the optical and magnetic properties of ZnO NWs, hence paving the way for future spintronics and spin-polarized optoelectronics applications.Room-temperature ferromagnetism in the large and direct bandgap diluted magnetic semiconductor zinc oxide (ZnO) is attributed to the intrinsic defects and p-orbital–p-orbital (p–p) coupling interaction. 相似文献
79.
Imayavaramban Lakshmanan Sanjib Chaudhary Raghupathy Vengoji Parthasarathy Seshacharyulu Satyanarayana Rachagani Joseph Carmicheal Rahat Jahan Pranita Atri Ramakanth ChirravuriVenkata Rohitesh Gupta Saravanakumar Marimuthu Naveenkumar Perumal Sanchita Rauth Sukhwinder Kaur Kavita Mallya Lynette M. Smith Subodh M. Lele Moorthy P. Ponnusamy Mohd W. Nasser Ravi Salgia Surinder K. Batra Apar Kishor Ganti 《Molecular oncology》2021,15(7):1866
80.
Vishal M. Balaramnavar Khurshid Ahmad Mohd Saeed Irfan Ahmad Mehnaz Kamal Talha Jawaid 《RSC advances》2020,10(70):42765
Correction for ‘Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro’ by Vishal M. Balaramnavar et al., RSC Adv., 2020, 10, 40264–40275, DOI: 10.1039/D0RA06038K.The authors regret that the name of one of the authors (Talha Jawaid) was shown incorrectly in the original article. The corrected author list is as shown above.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers. 相似文献